U.S. markets close in 2 hours 22 minutes
  • S&P 500

    3,633.97
    +56.38 (+1.58%)
     
  • Dow 30

    30,034.14
    +442.87 (+1.50%)
     
  • Nasdaq

    12,034.05
    +153.41 (+1.29%)
     
  • Russell 2000

    1,861.17
    +42.87 (+2.36%)
     
  • Crude Oil

    44.95
    +1.89 (+4.39%)
     
  • Gold

    1,803.90
    -33.90 (-1.84%)
     
  • Silver

    23.30
    -0.34 (-1.43%)
     
  • EUR/USD

    1.1881
    +0.0035 (+0.30%)
     
  • 10-Yr Bond

    0.8780
    +0.0210 (+2.45%)
     
  • GBP/USD

    1.3355
    +0.0033 (+0.25%)
     
  • USD/JPY

    104.5400
    +0.0520 (+0.05%)
     
  • BTC-USD

    19,112.66
    +660.70 (+3.58%)
     
  • CMC Crypto 200

    379.10
    +9.35 (+2.53%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Seres Therapeutics (MCRB) in Focus: Stock Moves 10.8% Higher

Zacks Equity Research
·1 min read

Seres Therapeutics, Inc. MCRB was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 20.5% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Seres Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Seres Therapeutics, Inc. Price

Seres Therapeutics, Inc. Price
Seres Therapeutics, Inc. Price

Seres Therapeutics, Inc. price | Seres Therapeutics, Inc. Quote

Investors interested in the Medical - Biomedical and Genetics industry may consider Applied Therapeutics Inc. APLT, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks to Soar Past the Pandemic:

In addition to the companies you learned about above, we invite you to learn about 5 cutting-edge stocks that could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of the decade.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Seres Therapeutics, Inc. (MCRB) : Free Stock Analysis Report
 
Applied Therapeutics Inc. (APLT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research